Biogen Inc. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Indemnification Agreements (2 contracts)
- Marketing Agreements (1)
- Settlement Agreements (1)
- Termination Agreements (1)
- Voting Agreements (3)
- JVA Termination Agreement, by and among Biogen Therapeutics Inc., Samsung BioLogics Co., Ltd. and Samsung Bioepis Co., Ltd, dated April 20, 2020 (Filed With SEC on February 14, 2024)
- Voting and Support Agreement, dated as of July 28, 2023, by and among Biogen Inc., River Acquisition, Inc. and each stockholder of Reata Pharmaceuticals, Inc., set forth on... (Filed With SEC on July 31, 2023)
- Voting and Support Agreement, dated as of July 28, 2023, by and among Biogen Inc., River Acquisition, Inc. and each stockholder of Reata Pharmaceuticals, Inc., set forth on... (Filed With SEC on July 31, 2023)
- Voting and Support Agreement, dated as of July 28, 2023, by and among Biogen Inc., River Acquisition, Inc. and each stockholder of Reata Pharmaceuticals, Inc., set forth on... (Filed With SEC on July 31, 2023)
- SETTLEMENT AND LICENSE AGREEMENT among Biogen Swiss Manufacturing GmbH, Biogen International Holding Ltd., Forward Pharma A/S and Each of the Parties Listed on Appendix I Dated as... (Filed With SEC on February 1, 2017)
- Indemnification Agreement (Filed With SEC on June 7, 2011)
- EX-10.1 Form of indemnification agreement for directors (Filed With SEC on October 17, 2008)
- Ex 10.48 Antegren Development and Marketing Coll (Filed With SEC on March 14, 2003)